BRAF and colorectal carcinoma: BRAF V600 point mutations (V600E being the most frequent) account for 70–78% of the total BRAF mutations in CRC and create active monomers not needing homo- or hetero-dimerization with CRAF to activate the Mek-Erk pathway [4].